Related references
Note: Only part of the references are listed.Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer
Lara A. Dunn et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer
Changlei Xi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
A phase 1/2a trial of docetaxel plus ribavirin for reprogramming efficacy in patients with progressive metastatic castration resistant prostate cancer who have previously received docetaxel alone: DRREEM trial.
Takeo Kosaka et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Trends in childhood leukemia incidence over two decades from 1992 to 2013
Jessica L. Barrington-Trimis et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic
F. Volpin et al.
ONCOGENE (2017)
Autophagy suppression sensitizes glioma cells to IMP dehydrogenase inhibition-induced apoptotic death
Andjelka M. Isakovic et al.
EXPERIMENTAL CELL RESEARCH (2017)
A clinical study to evaluate the efficacy and safety of docetaxel with ribavirin in patients with progressive castration resistant prostate cancer who have previously received docetaxel alone.
Takeo Kosaka et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma
Dehua Dai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas
Biljana Culjkovic-Kraljacic et al.
BLOOD (2016)
Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E
Laurent Volpon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Genetic and Pharmacologic Inhibition of eIF4E Reduces Breast Cancer Cell Migration, Invasion, and Metastasis
Filippa Pettersson et al.
CANCER RESEARCH (2015)
A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E
Sarit Assouline et al.
HAEMATOLOGICA (2015)
Intensified Chemotherapy Without Sct in Infant All: Results From COG P9407 (Cohort 3)
ZoAnn E. Dreyer et al.
PEDIATRIC BLOOD & CANCER (2015)
Anti-tumor effect of ribavirin in combination with interferon-α on renal cell carcinoma cell lines in vitro
Lichen Teng et al.
CANCER CELL INTERNATIONAL (2014)
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation
Hiba Ahmad Zahreddine et al.
NATURE (2014)
Efficacy of ribavirin against malignant glioma cell lines
Akiyoshi Ogino et al.
ONCOLOGY LETTERS (2014)
MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL
Ari L. Landon et al.
NATURE COMMUNICATIONS (2014)
Conformational changes induced in the eukaryotic translation initiation factor eIF4E by a clinically relevant inhibitor, ribavirin triphosphate
Laurent Volpon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia
Karen A. Urtishak et al.
BLOOD (2013)
Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Maria Cristina Manara et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Drug Repurposing for Gastrointestinal Stromal Tumor
Ziyan Y. Pessetto et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study
Huining Kang et al.
BLOOD (2012)
An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells
Ingeborg M. M. van Leeuwen et al.
CELL CYCLE (2012)
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Stephen P. Hunger et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases
Kui Xu et al.
BRIEFINGS IN BIOINFORMATICS (2011)
Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer
Filippa Pettersson et al.
CLINICAL CANCER RESEARCH (2011)
Interpretation of Cellular Proliferation Data: Avoid the Panglossian
Mario Roederer
CYTOMETRY PART A (2011)
In silico repositioning of approved drugs for rare and neglected diseases
Sean Ekins et al.
DRUG DISCOVERY TODAY (2011)
MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia
Diana Schotte et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach
Andrew S. Moore et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2011)
Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens
B. C. Kraljacic et al.
LEUKEMIA (2011)
Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants
Ronald W. Stam et al.
BLOOD (2010)
An Improved Technique for Calculating Relative Response in Cellular Proliferation Experiments
Mark E. Munson
CYTOMETRY PART A (2010)
The eIF2 Kinase GCN2 Is Essential for the Murine Immune System to Adapt to Amino Acid Deprivation by Asparaginase
Piyawan Bunpo et al.
JOURNAL OF NUTRITION (2010)
Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies
N. Chapuis et al.
LEUKEMIA (2010)
Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?
Katherine L. B. Borden et al.
LEUKEMIA & LYMPHOMA (2010)
HOXA9 is required for survival in human MLL-rearranged acute leukemias
Joerg Faber et al.
BLOOD (2009)
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
Sarit Assouline et al.
BLOOD (2009)
Acute Leukemia as a Secondary Malignancy in Children and Adolescents Current Findings and Issues
Nobuko Hijiya et al.
CANCER (2009)
c-Myc and eIF4F Constitute a Feedforward Loop That Regulates Cell Growth: Implications for Anticancer Therapy
Chen-Ju Lin et al.
CANCER RESEARCH (2009)
Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients
Luca Trentin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
GCN2 Protein Kinase Is Required to Activate Amino Acid Deprivation Responses in Mice Treated with the Anti-cancer Agent L-Asparaginase
Piyawan Bunpo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Role of Nucleoside Transporters in the Erythrocyte Disposition and Oral Absorption of Ribavirin in the Wild-Type and Equilibrative Nucleoside Transporter 1(-/-) Mice
Christopher J. Endres et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Stability of Eukaryotic Translation Initiation Factor 4E mRNA Is Regulated by HuR, and This Activity Is Dysregulated in Cancer
Ivan Topisirovic et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Original Research: Intravenous Ribavirin-Review of the FDA's Emergency Investigational New Drug Database (1997-2008) and Literature Review
Andrea Riner et al.
POSTGRADUATE MEDICINE (2009)
Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer
Biljana Culjkovic et al.
JOURNAL OF ONCOLOGY (2009)
Ribavirin targets eIF4E dependent Akt survival signaling
Keith Tan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation
Blaine W. Robinson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The eIF4E RNA regulon promotes the Akt signaling pathway
Biljana Culjkovic et al.
JOURNAL OF CELL BIOLOGY (2008)
Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia
Lei Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dissecting eIF4E action in tumorigenesis
Hans-Guido Wendel et al.
GENES & DEVELOPMENT (2007)
Is cell death a critical end point for anticancer therapies or is cytostasis sufficient?
Olivier Rixe et al.
CLINICAL CANCER RESEARCH (2007)
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
Rob Pieters et al.
LANCET (2007)
Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation
Yael Mamane et al.
PLOS ONE (2007)
Controlling gene expression through RNA regulons - The role of the eukaryotic translation initiation factor eIF4E
Biljana Culjkovic et al.
CELL CYCLE (2007)
Anthracycline cardiotoxicity in long-term survivors of childhood cancer
Rebecca E. Scully et al.
CARDIOVASCULAR TOXICOLOGY (2007)
eIF4E is a central node of an RNA regulon that governs cellular proliferation
Biljana Culjkovic et al.
JOURNAL OF CELL BIOLOGY (2006)
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group
Joanne M. Hilden et al.
BLOOD (2006)
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL
DT Teachey et al.
BLOOD (2006)
Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy
MH Cheok et al.
NATURE REVIEWS CANCER (2006)
Further evidence that ribavirin interacts with eIF4E
A Kentsis et al.
RNA (2005)
In vitro and in vivo influenza virus-inhibitory effects of viramidine
RW Sidwell et al.
ANTIVIRAL RESEARCH (2005)
Translational control in stress and apoptosis
M Holcik et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels
I Topisirovic et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype
NL Ramakers-van Woerden et al.
LEUKEMIA (2004)
Acute myeloid leukemia cells in G0 phase of the cell cycle that are unresponsive to conventional chemotherapy are sensitive to treatment with granulocyte-macrophage colony-stimulating factor/diphtheria toxin fusion proteins
I Jedema et al.
EXPERIMENTAL HEMATOLOGY (2004)
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment
A Holleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
A Kentsis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities
I Topisirovic et al.
CANCER RESEARCH (2004)
Pharmacokinetic studies in children with cancer
E Groninger et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase
K Mihara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis
I Topisirovic et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement
T Imamura et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Safety issues related to the administration of ribavirin
LR Krilov
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia:: Multi-institutional collaborative study
BM Frost et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2002)
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis
K Boon et al.
EMBO JOURNAL (2001)
A multifactor complex of eIFI, cIF2, eIF3, eIF5, and tRNA(i)(Met) promotes initiation complex assembly and couples GTP hydrolysis to AUG recognition
K Asano et al.
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY (2001)
Ribavirin-induced resistance to heat shock, inhibition of the Ras-Raf-1 pathway and arrest in G1
S Vallée et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
